Bradley Furlong

Bradley Furlong

Auto-generated profile, based on publicly available information

Bradley Furlong

Primary Healthcare Research Unit, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2025 in BMJ Evidence-Based Medicine
Verified
Journal Article
Open access
PDF file
ACAidan G Cashin
Aidan G Cashin
BFBradley M Furlong
Bradley M Furlong
SKSteven J Kamper
Steven J Kamper
DCDiana De Carvalho
Diana De Carvalho
LMLuciana Ac Machado
Luciana Ac Machado
AHAmanda M Hall
Amanda M Hall
Objectives To investigate the efficacy of non-surgical and non-interventional treatments for adults with low back pain compared with placebo. Eligibility criteria Randomised controlled trials evaluating non-surgical and non-interventional treatments compared with placebo or sham in adults (≥18 years) reporting non-specific low back pain. Information sources MEDLINE, CINAHL, EMBASE, PsychInfo and Cochrane Central Register of Controlled Trials were searched from inception to 14 April 2023. Risk of bias Risk of bias of included studies was assessed using the 0 to 10 PEDro Scale. Synthesis of results Random effects meta-analysis was used to estimate pooled effects and corresponding 95% confidence intervals on outcome pain intensity (0 to 100 scale) at first assessment post-treatment for each treatment type and by duration of low back pain—(sub)acute (<12 weeks) and chronic (≥12 weeks). Certainty of the evidence was assessed using the Grading of Recommendations Assessment (GRADE) approach. Results A total of 301 trials (377 comparisons) provided data on 56 different treatments or treatment combinations. One treatment for acute low back pain (non-steroidal anti-inflammatory drugs (NSAIDs)), and five treatments for chronic low back pain (exercise, spinal manipulative therapy, taping, antidepressants, transient receptor potential vanilloid 1 (TRPV1) agonists) were efficacious; effect sizes were small and of moderate certainty. Three treatments for acute low back pain (exercise, glucocorticoid injections, paracetamol), and two treatments for chronic low back pain (antibiotics, anaesthetics) were not efficacious and are unlikely to be suitable treatment options; moderate certainty evidence. Evidence is inconclusive for remaining treatments due to small samples, imprecision, or low and very low certainty evidence. Conclusions The current evidence shows that one in 10 non-surgical and non-interventional treatments for low back pain are efficacious, providing only small analgesic effects beyond placebo. The efficacy for the majority of treatments is uncertain due to the limited number of randomised participants and poor study quality. Further high-quality, placebo-controlled trials are warranted to address the remaining uncertainty in treatment efficacy along with greater consideration for placebo-control design of non-surgical and non-interventional treatments. Trial registration number OSF Registries; https://osf.io/2dk9z.

12 October 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BFBradley Furlong
Bradley Furlong
HEHolly Etchegary
Holly Etchegary
KAKris Aubrey-Bassler
Kris Aubrey-Bassler
MSMichelle Swab
Michelle Swab
APAndrea Pike
Andrea Pike
AHAmanda Hall
Amanda Hall
Introduction: Guidelines recommend patient education materials (PEMs) for low back pain (LBP), but no systematic review has assessed PEMs on their own. We investigated the effectiveness of PEMs on process, clinical, and health system outcomes for LBP and sciatica. Methods: Systematic searches were performed in MEDLINE, EMBASE, CINAHL, PsycINFO, SPORTDiscus, trial registries and grey literature through OpenGrey. We included randomized controlled trials of PEMs for LBP. Data extraction, risk of bias, and quality of evidence gradings were performed independently by two reviewers. Standardized mean differences or risk ratios and 95% confidence intervals were calculated, and effect sizes pooled using random-effects models. Analyses of acute/subacute LBP were performed separately from chronic LBP at immediate, short, medium, and long-term (6, 12, 24, and 52 weeks, respectively). Results: 27 studies were identified. Compared to usual care for chronic LBP, we found moderate to low-quality evidence that PEMs improved pain intensity at immediate (SMD = -0.16 [95% CI: -0.29, -0.03]), short (SMD = -0.44 [95% CI: -0.88, 0.00]), medium (SMD = -0.53 [95% CI: -1.01, -0.05]), and long-term (SMD = -0.21 [95% CI: -0.41, -0.01]), medium-term disability (SMD = -0.32 [95% CI: -0.61, -0.03]), quality of life at short (SMD = -0.17 [95% CI: -0.30, -0.04]) and medium-term (SMD = -0.23 [95% CI: -0.41, -0.04]) and very low-quality evidence that PEMs improved global improvement ratings at immediate (SMD = -0.40 [95% CI: -0.58, -0.21]), short (SMD = -0.42 [95% CI: -0.60, -0.24]), medium (SMD = -0.46 [95% CI: -0.65, -0.28]), and long-term (SMD = -0.43 [95% CI: -0.61, -0.24]). We found very low-quality evidence that PEMs improved pain self-efficacy at immediate (SMD = -0.21 [95% CI: -0.39, -0.03]), short (SMD = -0.25 [95% CI: -0.43, -0.06]), medium (SMD = -0.23 [95% CI: -0.41, -0.05]), and long-term (SMD = -0.32 [95% CI: -0.50, -0.13]), and reduced medium-term fear-avoidance beliefs (SMD = -0.24 [95% CI: -0.43, -0.06]) and long-term stress (SMD = -0.21 [95% CI: -0.39, -0.03]). Compared to usual care for acute LBP, we found high to moderate-quality evidence that PEMs improved short-term pain intensity (SMD = -0.24 [95% CI: -0.42, -0.06]) and immediate-term quality of life (SMD = -0.24 [95% CI: -0.42, -0.07]). We found low to very low-quality evidence that PEMs increased knowledge at immediate (SMD = -0.51 [95% CI: -0.72, -0.31]), short (SMD = -0.48 [95% CI: -0.90, -0.05]), and long-term (RR = 1.28 [95% CI: 1.10, 1.49]) and pain self-efficacy at short (SMD = -0.78 [95% CI: -0.98, -0.58]) and long-term (SMD = -0.32 [95% CI: -0.52, -0.12]). We found moderate to very low-quality evidence that PEMs reduced short-term days off work (SMD = -0.35 [95% CI: -0.63, -0.08]), long-term imaging referrals (RR = 0.60 [95% CI: 0.41, 0.89]), and long-term physician visits (SMD = -0.16 [95% CI: -0.26, -0.05]). Compared to other interventions (e.g., yoga, Pilates), PEMs had no effect or were less effective for acute/subacute and chronic LBP. Conclusions: There was a high degree of variability across outcomes and time points, but providing PEMs appears favorable to usual care as we observed many small, positive patient and system impacts for acute/subacute and chronic LBP. PEMs were generally less effective than other interventions; however, no cost effectiveness analyses were performed to weigh the relative benefits of these interventions to the likely less costly PEMs.

3 August 2021 in Implementation Science Communications
Verified
Journal Article
Open access
PDF file
AHAmanda M. Hall
Amanda M. Hall
GFGerd M. Flodgren
Gerd M. Flodgren
HRHelen L. Richmond
Helen L. Richmond
SWSheila Welsh
Sheila Welsh
JTJacqueline Y. Thompson
Jacqueline Y. Thompson
ASAndrea Sherriff
Andrea Sherriff
Background: The champion model is increasingly being adopted to improve uptake of guideline-based care in long-term care (LTC). Studies suggest that an on-site champion may improve the quality of care residents’ health outcomes. This review assessed the effectiveness of the champion on staff adherence to guidelines and subsequent resident outcomes in LTC homes. Method: This was a systematic review and meta-analyses of randomised controlled trials. Eligible studies included residents aged 65 or over and nursing staff in LTC homes where there was a stand-alone or multi-component intervention that used a champion to improve staff adherence to guidelines and resident outcomes. The measured outcomes included staff adherence to guidelines, resident health outcomes, quality of life, adverse events, satisfaction with care, or resource use. Study quality was assessed with the Cochrane Risk of Bias tool; evidence certainty was assessed using the GRADE approach. Results: After screening 4367 citations, we identified 12 articles that included the results of 1 RCT and 11 cluster-RCTs. All included papers evaluated the effects of a champion as part of a multicomponent intervention. We found low certainty evidence that champions as part of multicomponent interventions may improve staff adherence to guidelines. Effect sizes varied in magnitude across studies including unadjusted risk differences (RD) of 4.1% [95% CI: − 3%, 9%] to 44.8% [95% CI: 32%, 61%] for improving pressure ulcer prevention in a bed and a chair, respectively, RD of 44% [95% CI: 17%, 71%] for improving depression identification and RD of 21% [95% CI: 12%, 30%] for improving function-focused care to residents. Conclusion: Champions may improve staff adherence to evidence-based guidelines in LTC homes. However, methodological issues and poor reporting creates uncertainty around these findings. It is premature to recommend the widespread use of champions to improve uptake of guideline-based care in LTC without further study of the champion role and its impact on cost. Trial registration: PROSPERO CRD42019145579. Registered on 20 August 2019.

2 September 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
BFBradley Furlong
Bradley Furlong
KAKris Aubrey-Bassler
Kris Aubrey-Bassler
HEHolly Etchegary
Holly Etchegary
APAndrea Pike
Andrea Pike
GDGeorgia Darmonkow
Georgia Darmonkow
AHAmanda Hall
Amanda Hall
Introduction: Low back pain accounts for more disability than any other musculoskeletal condition and is associated with severe economic burden. Patients commonly present with negative beliefs about low back pain and this can have detrimental effects on their health outcomes. Providing evidence-based, patient-centred education that meets patient needs could help address these negative beliefs and alleviate the substantial low back pain burden. The primary aim of this review is to investigate the effectiveness of patient education materials on immediate process, clinical and health system outcomes. Methods and analysis: The search strategy was developed in collaboration with a librarian and systematic searches will be performed in MEDLINE, EMBASE, CINAHL, PsycINFO and SPORTDiscus. We will also search trial registries and grey literature through the OpenGrey database. Study selection will include a title and abstract scan and full-text review by two authors. Only randomised controlled trials will be included in this review. Trials must include patients with low back pain or sciatica and investigate educational interventions with at least one of the following contrasts: (1) education alone versus no intervention; (2) education alone versus another intervention; (3) education in addition to another intervention versus the same intervention with no education. Data extraction, risk of bias and grading of the quality of evidence will be performed independently by two reviewers. Risk of bias will be assessed using the PEDro scale, and the quality of evidence will be assessed with the Grades of Recommendation, Assessment, Development and Evaluation approach. A random-effects model will be used for each contrast, and results will be pooled if the participants, interventions, and outcomes are homogeneous. If heterogeneity is high (I 2 >75%), we will evaluate the magnitude and direction of the differences in effect sizes across studies to determine if it remains reasonable to pool the results. Analyses of acute and subacute low back pain (less than 12 weeks duration) will be performed separately from chronic low back pain (12 weeks or greater duration). Likewise, analyses of short-term (less than 6 months) and long-term (6 months or greater) follow-up will be performed separately. Subgroup analyses will be performed on non-specific low back pain, sciatica and mixed populations. Ethics and dissemination: Ethical approval is not required for this review. This study, along with its results, will be published in a peer-reviewed journal.

4 October 2025 in Musculoskeletal Science and Practice
Verified
Journal Article
Open access
BFBradley Furlong
Bradley Furlong
MFMona Frey
Mona Frey
SDSimon Davidson
Simon Davidson
GFGiovanni Ferreira
Giovanni Ferreira
HEHolly Etchegary
Holly Etchegary
AHAmanda Hall
Amanda Hall
Patients have unhelpful beliefs about low back pain (LBP), which are associated with worse outcomes. Education may modify these beliefs, but patients with LBP rarely receive education in practice. Patient education materials (PEMs) are a quick, inexpensive intervention to support information provision. assess PEMs for understandability, actionability, quality, readability, accuracy, comprehensiveness, and coverage of information about patients' needs to identify the best PEMs for practice. We searched published literature for PEMs tested in randomized trials or recommended in clinical guidelines. We used the Patient Education Materials Assessment Tool (PEMAT) to assess understandability and actionability, DISCERN to assess quality, the Patient Information and Education Needs Checklist for Low Back Pain (PINE-LBP) to assess information need coverage, and the Flesch Reading Ease (FRE) and Flesch-Kincaid Grade-Level (FKGL) algorithms to assess readability. We assessed accuracy (proportion of treatment recommendations aligning with guidelines) and comprehensiveness (proportion of correctly covered guideline recommendations), and qualitatively synthesized PEM content relating to 21 information and education needs about LBP. Nineteen PEMs were included. None were actionable or comprehensive, and many had inaccurate treatment recommendations. There was considerable variation and conflicting information in the content provided across PEMs. Only the My Back Pain website met acceptable standards for more than half (4/7) outcomes. Educational messaging for LBP varies substantially and PEMs require improvement in various areas. The My Back Pain website met acceptable standards across most outcomes and may be the best available option for practice.

29 November 2023 in Journal of Physiotherapy
Verified
Journal Article
Open access
BFBradley Furlong
Bradley Furlong
AHAmanda Hall
Amanda Hall